Regeneron’s Muscle-Preserving Drug Boosts Weight Loss Benefits with Wegovy in Clinical Trials

Mid-stage trial shows trevogrumab helps patients retain muscle mass while enhancing fat loss when combined with Wegovy

Topline

A new mid-stage trial shows that Regeneron’s experimental drug trevogrumab, when combined with Wegovy, can help patients preserve more than half of their muscle mass while boosting fat loss marking a potential breakthrough in obesity treatment.

Study Details

The study investigated whether adding Regeneron's trevogrumab to Novo Nordisk’s Wegovy coul…